LLY
Eli Lilly and Company · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website lilly.com
- Employees(FY) 39000
- ISIN US5324571083
Performance
+5.5%
1W
-0.82%
1M
+10.51%
3M
+31.14%
6M
+33.66%
YTD
+81.23%
1Y
Profile
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; Foghorn Therapeutics Inc., and PRISM BioLab Co.,Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Investment Analysis Report: Eli Lilly and Company (LLY)
Overview:
Eli Lilly and Company (LLY) is a major player in the pharmaceutical industry with a market capitalization of $731.19 billion. The company operates in the Health Technology sector and specializes in Pharmaceuticals. In this report, we will conduct a detailed analysis of LLY's finan...
Technical Analysis of LLY 2024-05-03
Overview:
In the last 5 trading days, LLY stock has shown a mix of price movements and technical indicators. The stock price fluctuated between 734.97 and 781.10, with varying volumes. The trend indicators suggest a slight bearish sentiment, while momentum indicators show a weakening trend. Volatility indicators indicate fluctuating price moveme...
Recent News & Updates
- 2024-05-08 02:04
- 2024-05-07 23:29
13 Best Stocks That Will Always Grow(Insidermonkey)
- 2024-05-07 19:19
- 2024-05-07 14:38
- 2024-05-07 11:30
- 2024-05-07 11:29
13 Best Stocks That Will Always Grow(Insider Monkey)
- 2024-05-07 11:02
Kevin O’Leary’s Stock Portfolio: 10 Stock Picks for 2024(Insider Monkey)
- 2024-05-07 09:51
- 2024-05-07 09:38
- 2024-05-07 02:30
3 Biotech Stocks to Double Your Money in the Next 24 Months(Investorplace)
- 2024-05-06 23:32
Lilly Declares Second-Quarter 2024 Dividend(Prnewswire)
- 2024-05-06 21:18
- 2024-05-06 21:00
- 2024-05-06 20:00
Mutual Funds Can't Get Enough Amazon, Broadcom(Yahoo Finance)
- 2024-05-06 19:06
Why Eli Lilly Stock Jumped by 4% Today(Motley Fool)
- 2024-05-06 15:05
- 2024-05-06 11:32
Lilly Declares Second-Quarter 2024 Dividend(PR Newswire)
- 2024-05-06 09:18
- 2024-05-06 09:00
- 2024-05-06 07:15
- 2024-05-06 04:10
2 Top Stocks That Could Make You Richer in 2024(Motley Fool)
- 2024-05-05 14:49
- 2024-05-05 06:55
3 No-Brainer Stocks to Buy in May(Motley Fool)
- 2024-05-04 08:30
- 2024-05-04 06:45
- 2024-05-04 05:26
- 2024-05-04 02:39
- 2024-05-04 00:37
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-05-03 17:33
- 2024-05-03 17:07
Page 1 of 10
previousnext